Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivano Amelio

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Genes and Immunity|December 20, 2018
Cell death pathologies: targeting death pathways and the immune system for cancer therapyFrancesca Pentimalli, Sandro Grelli, Nicola Di Daniele, et al.
Oncotarget|March 25, 2014
p63 transcriptionally regulates the expression of matrix metallopeptidase 13Ivana Celardo, Alexey Antonov, Ivano Amelio, et al.
Cell Death Discovery|July 2, 2025
Interplay between genes and social environment: from epigenetics to precision medicineSabrina Caporali, Simone Russo, Marcel Leist, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2012
Tissue-specific expression of p73 C-terminal isoforms in miceFrancesca Grespi, Ivano Amelio, Paola Tucci, et al.
Molecular Oncology|December 17, 2021
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancerCarlotta Zampieri, Emanuele Panatta, Vincenzo Corbo, et al.
Cancers|December 15, 2019
p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative MechanismsConsuelo Pitolli, Ying Wang, Eleonora Candi, et al.
Oncotarget|December 2, 2014
Bioinformatics analysis of the serine and glycine pathway in cancer cellsAlexey Antonov, Massimiliano Agostini, Maria Morello, et al.
Current Drug Targets|March 2, 2016
Polypharmacology of Approved Anticancer DrugsIvano Amelio, Andrey Lisitsa, Richard A Knight, et al.
Discover Oncology|February 24, 2022
Recent advances in cancer immunotherapyQiang Sun, Gerry Melino, Ivano Amelio, et al.
International Journal of Molecular Sciences|December 15, 2019
Do Mutations Turn p53 into an Oncogene?Consuelo Pitolli, Ying Wang, Mara Mancini, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Genes and Immunity|December 20, 2018
Cell death pathologies: targeting death pathways and the immune system for cancer therapyFrancesca Pentimalli, Sandro Grelli, Nicola Di Daniele, et al.
Oncotarget|March 25, 2014
p63 transcriptionally regulates the expression of matrix metallopeptidase 13Ivana Celardo, Alexey Antonov, Ivano Amelio, et al.
Cell Death Discovery|July 2, 2025
Interplay between genes and social environment: from epigenetics to precision medicineSabrina Caporali, Simone Russo, Marcel Leist, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2012
Tissue-specific expression of p73 C-terminal isoforms in miceFrancesca Grespi, Ivano Amelio, Paola Tucci, et al.
Molecular Oncology|December 17, 2021
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancerCarlotta Zampieri, Emanuele Panatta, Vincenzo Corbo, et al.
Cancers|December 15, 2019
p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative MechanismsConsuelo Pitolli, Ying Wang, Eleonora Candi, et al.
Oncotarget|December 2, 2014
Bioinformatics analysis of the serine and glycine pathway in cancer cellsAlexey Antonov, Massimiliano Agostini, Maria Morello, et al.
Current Drug Targets|March 2, 2016
Polypharmacology of Approved Anticancer DrugsIvano Amelio, Andrey Lisitsa, Richard A Knight, et al.
Discover Oncology|February 24, 2022
Recent advances in cancer immunotherapyQiang Sun, Gerry Melino, Ivano Amelio, et al.
International Journal of Molecular Sciences|December 15, 2019
Do Mutations Turn p53 into an Oncogene?Consuelo Pitolli, Ying Wang, Mara Mancini, et al.
Pageof 10